Charles Cherington, Ten Percent Owner at Eterna Therapeutics, holds 7.37M shares in Comera Life Sciences Holdings (Ticker: CMRA), holds 556.47K shares in Eterna Therapeutics (Ticker: ERNA). Most recently, Charles Cherington Bought ― shares of Comera Life Sciences Holdings on Sep 11, 2023 for an estimated value of 1.05M.